Pasar al contenido principal

Nebreda descubre que la supresion de una proteína reduce los tumores de colon

IRB Barcelona en los medios
4 Nov 14

Images

Participantes

Contact

Imagen
Communication Officer
Tel.+34 93 40 37255

Artículo en la Opinión de Zamora sobre la investigación del investigador ICREA en el IRB Barcelona, Angel Rodríguez Nebreda, sobre las funciones de p53 en los tumores de colon y mama. Nebreda presentó los resultados sobre las proteínas quinasas p38 MAPK en el Centro de Investigación del Cáncer de Salamanca.

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).